# Safety and Tolerability of the Use of Copaiba in Patients With Oral Cancer Submitted to Radiotherapy

> **NCT05308732** · PHASE1 · ACTIVE_NOT_RECRUITING · sponsor: **Instituto Nacional de Cancer, Brazil** · enrollment: 20 (actual)

## Conditions studied

- Head and Neck Neoplasms
- Mucositis Oral
- Radiotherapy; Complications

## Interventions

- **DRUG:** Copaiba

## Key facts

- **NCT ID:** NCT05308732
- **Lead sponsor:** Instituto Nacional de Cancer, Brazil
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2021-05-11
- **Primary completion:** 2025-09-07
- **Final completion:** 2026-12
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2026-05-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05308732

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05308732, "Safety and Tolerability of the Use of Copaiba in Patients With Oral Cancer Submitted to Radiotherapy". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT05308732. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*